|Bid||20.76 x 900|
|Ask||21.32 x 900|
|Day's range||20.90 - 21.52|
|52-week range||17.09 - 53.46|
|Beta (5Y monthly)||1.51|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||35.00|
Personalis (PSNL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MENLO PARK, Calif., July 21, 2021--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its second quarter 2021 financial results after the market closes on Wednesday, August 4, 2021. In conjunction with the release, the Company will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
MENLO PARK, Calif., Jun 22, 2021--Personalis Announces NeXT Level Biomarkers Symposium